Wells Fargo & Company Novan, Inc. Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.41 - $1.4 $13 - $46	33 Added 19.53%	202 $0
Q1 2023 May 12, 2023	BUY	$1.05 - $2.04 $25 - $48	24 Added 16.55%	169 $0
Q4 2022 Feb 13, 2023	BUY	$0.82 - $1.48 $3 - $5	4 Added 2.84%	145 $0
Q3 2022 Nov 14, 2022	BUY	$1.76 - $3.03 $22 - $39	13 Added 10.16%	141 $0
Q2 2022 Aug 12, 2022	BUY	$2.29 - $3.86 $27 - $46	12 Added 10.34%	128 $0
Q1 2022 May 16, 2022	SELL	$2.95 - $4.41 $59 - $88	-20 Reduced 14.71%	116 $0
Q4 2021 Feb 14, 2022	BUY	$4.03 - $8.15 $173 - $350	43 Added 46.24%	136 $0
Q3 2021 Nov 15, 2021	BUY	$7.48 - $10.17 $22 - $30	3 Added 3.33%	93 $1,000
Q2 2021 Aug 16, 2021	BUY	$7.8 - $17.35 $702 - $1,561	90 New	90 $1,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.